Unraveling a Rare Complication: BCG-associated Brain Abscess in Wiskott–aldrich Syndrome: A Case Report
Abstract
Wiskott–aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency characterized by thrombocytopenia, eczema, and recurrent infections. Live vaccines, such as Bacillus Calmette–Guérin (BCG), routinely administered in tuberculosis-endemic regions, may cause severe complications in undiagnosed patients.
We report a 2-year-old boy with genetically confirmed WAS who developed a rare BCG-related brain abscess. The patient initially presented with neonatal thrombocytopenia and eczema, followed by recurrent respiratory and gastrointestinal infections. Whole exome sequencing identified a pathogenic mutation in the WAS gene. During pre-hematopoietic stem cell transplantation (HSCT) evaluation, brain imaging revealed a large multiloculated right parieto-occipital abscess with significant mass effect. Surgical drainage was performed, and polymerase chain reaction confirmed Mycobacterium bovis (BCG strain).
Antitubercular therapy was initiated. Severe thrombocytopenia complicated management and necessitated splenectomy. Although platelet counts improved and infection was partially controlled, HSCT was postponed due to active infection. The patient subsequently died following a severe COVID-19 infection.
This case highlights the diagnostic and therapeutic challenges of BCG-related brain abscess in patients with WAS and underscores the importance of early genetic diagnosis, avoidance of live vaccines, and timely definitive treatment in primary immunodeficiencies.
2. Agarwal N, Lehrnbecher T, Burns LJ, Davies SM, Chiesa R, Filipovich AH, et al. Wiskott–Aldrich syndrome: healthcare utilization and disparities in transplant care. Sci Rep. 2021;11(1):4654.
3. Yoon SH, Kim HJ, Yoo KH, Sung KW, Koo HH, Kang HJ. IVS6+5G>A found in Wiskott–Aldrich syndrome and X-linked thrombocytopenia in a Korean family. Pediatr Blood Cancer. 2012;58(2):297–9.
4. Guerrero Espejo A, Tomás Dols S, Gestal MC. Twenty-one years of Wiskott–Aldrich syndrome in Spain: incidence, mortality, and gender bias. Rev Clin Esp. 2023;223(5):262–9.
5. Haskoloğlu Ş, Çetin M, Öztürk G, Yılmaz M, Kılıç SS, Tezcan İ, et al. Clinical features and outcomes of patients with Wiskott–Aldrich syndrome: a single-center experience. Turk J Haematol. 2020;37(4):271–81.
6. Buchbinder D, Nugent DJ, Filipovich AH. Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet. 2014;7:55–66.
7. Hosahalli Vasanna S, Pereda MA, Dalal J. Clinical features and integrated management strategies for Wiskott–Aldrich syndrome. J Multidiscip Healthc. 2021;14:3497–512.
8. Rivers E, Thrasher AJ. Wiskott–Aldrich syndrome protein: emerging mechanisms in immunity. Eur J Immunol. 2017;47(11):1857–66.
9. Fazlollahi MR, Ebrahimi M, Yazdani R, Abolhassani H, Aghamohammadi A, Rezaei N, et al. Complications of Bacillus Calmette–Guérin vaccine as an early warning sign of inborn errors of immunity: a report of 197 patients. Front Immunol. 2024;15:1477499.
10. Sudhakar M, Sharma M, Jindal AK, Rawat A, Suri D, Singh S, et al. Autoimmunity in Wiskott–Aldrich syndrome: updated perspectives. Appl Clin Genet. 2021;14:363–88.
11. Blundell MP, Bouma G, Metelo J, Worth A, Calle Y, Cowell LA, et al. The Wiskott–Aldrich syndrome: the actin cytoskeleton and immune cell function. Dis Markers. 2010;29(3-4):157–75.
12. Vallée TC, Albert MH, Notarangelo LD, Ochs HD, Filipovich AH, Moratto D, et al. Wiskott–Aldrich syndrome: genotype as a biomarker for disease severity and survival. Blood. 2024;143(24):2504–16.
13. Machuca I, Casado JL, Navas E, Rivero A, Torre-Cisneros J, Moreno A, et al. Tuberculosis in immunosuppressed patients. Enferm Infecc Microbiol Clin. 2018;36(6):366–74.
14. McGrath B, Broadhurst M, Roman C. Infectious disease considerations in immunocompromised patients. JAAPA. 2020;33(9):16–25.
15. Shearer WT, Fleisher TA, Buckley RH, Ballas Z, Ballow M, Blaese RM, et al. Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol. 2014;133(4):961–6.
16. Abolhassani H, Azizi G, Sharifi L, Yazdani R, Mohsenzadegan M, Delavari S, et al. National consensus on diagnosis and management guidelines for primary immunodeficiency. 2019.
17. Hasan T, Au E, Chen S, Tong A, Wong G. Screening and prevention for latent tuberculosis in immunosuppressed patients: a systematic review. BMJ Open. 2018;8(9):e022445.
18. Garnacho-Montero J, Barrero-García I, León-Moya C. Fungal infections in immunocompromised critically ill patients. J Intensive Med. 2024;4(3):299–306.
19. Monteiro FMR, Pina S, Mota M, Ferreira A, Nunes J, Carvalho A. Salmonella brain abscess in a sickle cell disease patient: case report. Reports. 2024;7:Article number as published.
20. Hanafiah M, Mohamad M, Abdullah JM, Idris B. Intraventricular tuberculosis abscess in an immunocompromised patient. Asian Biomed. 2021;15(6):293–7.
21. Jung J, Shin I, Choi Y. Nontuberculous mycobacterial abscess mimicking brain tumor. Brain Tumor Res Treat. 2023;11(3):219–22.
22. Cisse Y, Diallo M, Ndiaye M, Diop A, Ba PD, Ka D, et al. Recurrent tuberculous cerebellar abscess: case study and literature review. Int J Surg Case Rep. 2021;81:105832.
23. Roy S, Gupta SS, Muzaffar SN. Intracranial microhemorrhages in tubercular meningitis: a case report. Cureus. 2023;15(7):e41462.
24. Parikh KA. Diffuse cerebral microhemorrhages in Wiskott–Aldrich syndrome: a rare radiological manifestation. Case Rep Clin Radiol. 2025;3:130–3.
| Files | ||
| Issue | Articles in Press | |
| Section | Case Report(s) | |
| Keywords | ||
| Brain abscess Mycobacterium bovis Primary immunodeficiency diseases Wiskott-aldrich syndrome | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
